Nan-Fu Chen Selected Research

Nan-Fu Chen Research Topics

Disease

7	Hyperalgesia 02/2023 - 09/2012
6	Glioblastoma (Glioblastoma Multiforme) 04/2023 - 01/2018
5	Neoplasms (Cancer) 02/2024 - 03/2015
5	Neuralgia (Stump Neuralgia) 02/2023 - 12/2013
4	Mitochondrial Diseases (Mitochondrial Disease) 07/2023 - 01/2020
4	Neuroinflammatory Diseases 09/2021 - 09/2012
4	Inflammation (Inflammations) 03/2021 - 06/2014
3	Osteosarcoma (Osteogenic Sarcoma) 07/2023 - 01/2018
3	Pain (Aches) 09/2021 - 12/2016
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2018 - 09/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2023 - 09/2021
2	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2015
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2019
2	Neuroblastoma 09/2016 - 04/2011
2	Gliosis 04/2016 - 09/2015
1	Frailty 12/2023
1	Osteoarthritis 08/2023
1	Brain Neoplasms (Brain Tumor) 07/2022
1	Carcinogenesis 06/2021
1	Gouty Arthritis 07/2020
1	Osteolysis 07/2020
1	Infections 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Cerebral Hemorrhage 01/2018
1	Hypersensitivity (Allergy) 12/2016
1	Lymphoma (Lymphomas) 10/2016
1	Leukemia 10/2016

Drug/Important Bio-Agent (IBA)

3	Analgesics (Analgesic Drugs)IBA 07/2023 - 06/2014
3	Therapeutic UsesIBA 03/2021 - 01/2018
3	Antimicrobial PeptidesIBA 01/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2011
2	Collagen Type II (Type II Collagen)IBA 08/2023 - 03/2021
2	sinularinIBA 07/2022 - 09/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021 - 02/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2019
2	AntioxidantsIBA 01/2020 - 01/2019
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2016 - 04/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 12/2013
2	TensinsIBA 04/2016 - 03/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2016 - 03/2015
2	CarrageenanIBA 06/2014 - 09/2012
1	Indicators and Reagents (Reagents)IBA 12/2023
1	Peptide Hydrolases (Proteases)FDA Link 08/2023
1	manoalideIBA 07/2023
1	PLIalphaIBA 07/2023
1	isoaaptamineIBA 04/2023
1	aaptamineIBA 02/2023
1	fumagillinIBA 09/2021
1	Angiogenesis InhibitorsIBA 09/2021
1	CytokinesIBA 09/2021
1	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2021
1	Temozolomide (Temodar)FDA LinkGeneric 06/2021
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 06/2021
1	Glucosamine (Dona)IBA 03/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2020
1	Uric Acid (Urate)IBA 07/2020
1	EtoricoxibIBA 07/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	splenotritin (TP3)IBA 01/2020
1	Morone saxatilis moronecidin proteinIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2020
1	Superoxide DismutaseIBA 01/2020
1	stellettin BIBA 02/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2019
1	Actins (F Actin)IBA 02/2019
1	TOR Serine-Threonine KinasesIBA 02/2019
1	heteroneminIBA 01/2019
1	CatalaseIBA 01/2019
1	EnzymesIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018
1	ProdigiosinIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	Antiphospholipid AntibodiesIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2017
1	p38 Mitogen-Activated Protein KinasesIBA 07/2017
1	SterolsIBA 10/2016
1	Cytotoxins (Cytolysins)IBA 10/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 09/2016
1	LipopolysaccharidesIBA 09/2016
1	11-dehydrosinulariolideIBA 09/2016
1	Chondroitin Sulfate ProteoglycansIBA 04/2016

Therapy/Procedure

4	Therapeutics 02/2024 - 11/2015
2	Oral Administration 08/2023 - 03/2021
1	Drug Therapy (Chemotherapy) 06/2021
1	Intra-Articular Injections 07/2020
1	Plasma Exchange 01/2018
1	Injections 12/2016
1	Spinal Injections 09/2016
1	Treatment Delay 04/2016